Navigation Links
MiMedx Group Announces Third Quarter 2011 Results
Date:10/26/2011

from human amniotic membrane.  "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix™ and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies, processed from the human amniotic membrane, utilize our proprietary Purion® process that was developed by our wholly-owned subsidiary, Surgical Biologics, to produce a safe, effective and minimally manipulated implant. Surgical Biologics is the leading supplier of amniotic tissue, having supplied over 35,000 implants to date to distributors and OEMs for application in the Ophthalmic, Orthopedics, Spine, Wound Care and Dental sectors of healthcare.

*Earnings before interest, taxes, depreciation, amortization and share based compensation is a non-GAAP financial measure and should not be considered a replacement for GAAP results.  For a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure, see accompanying table to this release.

Safe Harbor StatementThis press release includes statements that look forward in time or that express management's beliefs, expectations or hopes.  Such statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements include, but are not limited to the effect on fourth quarter revenue growth of the recent addition of key resources in the Company's sales organization, the Company's agreement with Affirmative Solutions, and potential OEM agreements, the Company's ability to achieve positive Adjusted EBITDA through revenue growth and expense controls, the increasing  enthusiasm for the Company's AmnioFix® and EpiFix® products, potential uses for the Company's amniotic membrane injectable
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. MiMedx Groups EpiFix® Receives American Podiatric Medical Association Seal of Approval
2. MiMedx Group Partners With Affirmative Solutions
3. MiMedx Group Receives FDA Clearance to Market Its HydroFix™ Ortho Shield™ Device
4. MiMedx Announces Launch of AmnioFix™ Nerve Wrap
5. MiMedx to Attend International Society for the Advancement of Spine Surgery Annual Meeting
6. MiMedx Group, Inc. Announces Release Date for First Quarter Results
7. MiMedx Completes Acquisition of Surgical Biologics
8. MiMedx Receives Additional CE Certification for Its HydroFix™ Technology
9. MiMedx Announces Agreement to Acquire Surgical Biologics
10. MiMedx Group, Inc. Announces Release Date for Second Quarter Results
11. MiMedx Group Announces Addition of Sales Director for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 NxStage Medical, Inc. (NASDAQ: ... products, announced today that the U.S. Food and ... to perform hemodialysis overnight while the patient is ... NxStage,s® System One is the first and only ... indication. Home nocturnal hemodialysis is ...
(Date:12/22/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ) ... Analysis of the US Medical Device Sector " ... http://photos.prnewswire.com/prnh/20130307/600769 This analysis ... identifies the key trends and rationale for undertaking ... and acquisitions. The study will be ...
(Date:12/22/2014)... MARLBOROUGH, Mass , Dec. 22, 2014 /PRNewswire/ -- ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today issued the following open ... Geert Cauwenbergh , Dr. Med. Sc. ... few days a number of inaccurate statements posted ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Therapeutics, Inc. today,announced completion of a Phase ... kappa opioid agonist, CR845, under development for ... drug candidate was safe and,well-tolerated after intravenous ... expected to be associated with clinical analgesic ...
... CyberKnife System at Oklahoma ... CyberKnife Center, ... global leader in the field of radiosurgery,announced today that the first ... was recently,installed at the Oklahoma CyberKnife, LLC in Tulsa, OK. The ...
Cached Medicine Technology:Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 2New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 2New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 3New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times 4
(Date:12/26/2014)... India Network Foundation, a non-profit US based ... today a new version of “ EasySelect ”, a ... plan for their visiting parents. The technology tool is ... process when choosing an insurance plan by showing the ... few clicks. Many elderly Asian Indian parents often find ...
(Date:12/26/2014)... Parker & Sons, Inc. a ... heating, cooling and plumbing contractor services throughout Arizona ... in 2014 with regard to air-conditioning systems. Residential ... known for its incredibly hot summers. Working with ... and details of a wide variety of systems ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Dylan Queen, a famous online company supplying women’s special ... prom dresses, most of which are priced under $200. ... the promotion is valid until Jan. 22, 2015; the ... market. , The prom dresses in this new collection ... strapless, empire strapless chiffon, one shoulder, floor-length, V-neck beading, ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... HPRT1 lead to very specific self-destructive behavior. Boys with ... slam their arms into doorways and otherwise harm themselves. ... gene don,t behave differently than normal mice. Researchers at ... related to HPRT1, present in humans but not in ...
... HealthDay Reporter , WEDNESDAY, July 27 (HealthDay News) -- ... doesn,t improve detection of invasive breast cancer, new research suggests. ... will be called back for further testing, according to the ... National Cancer Institute . ,All in all, we found ...
... News) -- Greater breast density is associated with an ... traits, new research says. In the study, published ... Journal of the National Cancer Institute , researchers used ... with breast cancer and a control group of 1,794 ...
... Using human breast cancer cells and the protein that causes fireflies ... some breast cancer cells become resistant to the anticancer effects of ... "dimmer switches" that apparently control how a breast cancer gene responds ... July 7 by Human Molecular Genetics , the scientists show ...
... 27, 2011) Using computed tomography (CT), researchers have identified ... with chronic obstructive pulmonary disease (COPD) that are associated with ... are published online in the journal Radiology . ... of the lungs, and is a leading cause of death ...
... measurements in humans show that potentially harmful haloacetic acids ... minutes after exposure to chlorinated water where HAAs form ... in the ACS journal Environmental Science & Technology ... the urine of swimming pool workers. Mercedes Gallego ...
Cached Medicine News:Health News:Gene gives clues to self-injurious behavior in rare disorder 2Health News:Computer-Aided Mammography Doesn't Improve Breast Cancer Detection: Study 2Health News:Computer-Aided Mammography Doesn't Improve Breast Cancer Detection: Study 3Health News:Greater Breast Density May Raise Cancer Risk 2Health News:Johns Hopkins researchers discover how some breast cancers alter their sensitivity to estrogen 2Health News:CT shows changes in lungs associated with COPD flare-ups 2
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
Inquire...
Chemically Resistant Sealing Mat for 384ch, Square Well Available Sterile...
96-well Silicone Compression Mat, Bulk...
Medicine Products: